The global Blood Cancer Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Blood Cancer Therapeutics market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Blood Cancer Therapeutics, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Blood Cancer Therapeutics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Blood Cancer Therapeutics revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Blood Cancer Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Blood Cancer Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Blood Cancer Therapeutics Market Report

Report Metric	Details
Report Name	Blood Cancer Therapeutics Market
CAGR	5%
Segment by Type	Chronic Myeloid Leukemia (CML) Acute Lymphocytic Leukemia (ALL) Chronic Lymphocytic Leukemia (CLL) Acute Myeloid Leukemia (AML)
Segment by Application	Cancer Research Centers Cancer Hospital Surgical Centers Clinics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Roche, Novartis, Boehringer Ingelheim, Pfizer, Sanofi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Blood Cancer Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Cancer Therapeutics companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood Cancer Therapeutics revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Blood Cancer Therapeutics Market report?

Ans: The main players in the Blood Cancer Therapeutics Market are AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Roche, Novartis, Boehringer Ingelheim, Pfizer, Sanofi

What are the Application segmentation covered in the Blood Cancer Therapeutics Market report?

Ans: The Applications covered in the Blood Cancer Therapeutics Market report are Cancer Research Centers, Cancer Hospital, Surgical Centers, Clinics

What are the Type segmentation covered in the Blood Cancer Therapeutics Market report?

Ans: The Types covered in the Blood Cancer Therapeutics Market report are Chronic Myeloid Leukemia (CML), Acute Lymphocytic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL), Acute Myeloid Leukemia (AML)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Blood Cancer Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Chronic Myeloid Leukemia (CML)

1.2.3 Acute Lymphocytic Leukemia (ALL)

1.2.4 Chronic Lymphocytic Leukemia (CLL)

1.2.5 Acute Myeloid Leukemia (AML)

1.3 Market by Application

1.3.1 Global Blood Cancer Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Cancer Research Centers

1.3.3 Cancer Hospital

1.3.4 Surgical Centers

1.3.5 Clinics

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Blood Cancer Therapeutics Market Perspective (2019-2030)

2.2 Global Blood Cancer Therapeutics Growth Trends by Region

2.2.1 Blood Cancer Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Blood Cancer Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Blood Cancer Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Blood Cancer Therapeutics Market Dynamics

2.3.1 Blood Cancer Therapeutics Industry Trends

2.3.2 Blood Cancer Therapeutics Market Drivers

2.3.3 Blood Cancer Therapeutics Market Challenges

2.3.4 Blood Cancer Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Blood Cancer Therapeutics by Players

3.1.1 Global Blood Cancer Therapeutics Revenue by Players (2019-2024)

3.1.2 Global Blood Cancer Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Blood Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Blood Cancer Therapeutics, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Blood Cancer Therapeutics Market Concentration Ratio

3.4.1 Global Blood Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Blood Cancer Therapeutics Revenue in 2023

3.5 Global Key Players of Blood Cancer Therapeutics Head office and Area Served

3.6 Global Key Players of Blood Cancer Therapeutics, Product and Application

3.7 Global Key Players of Blood Cancer Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Blood Cancer Therapeutics Breakdown Data by Type

4.1 Global Blood Cancer Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Blood Cancer Therapeutics Forecasted Market Size by Type (2025-2030)

5 Blood Cancer Therapeutics Breakdown Data by Application

5.1 Global Blood Cancer Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Blood Cancer Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Blood Cancer Therapeutics Market Size (2019-2030)

6.2 North America Blood Cancer Therapeutics Market Size by Type

6.2.1 North America Blood Cancer Therapeutics Market Size by Type (2019-2024)

6.2.2 North America Blood Cancer Therapeutics Market Size by Type (2025-2030)

6.2.3 North America Blood Cancer Therapeutics Market Share by Type (2019-2030)

6.3 North America Blood Cancer Therapeutics Market Size by Application

6.3.1 North America Blood Cancer Therapeutics Market Size by Application (2019-2024)

6.3.2 North America Blood Cancer Therapeutics Market Size by Application (2025-2030)

6.3.3 North America Blood Cancer Therapeutics Market Share by Application (2019-2030)

6.4 North America Blood Cancer Therapeutics Market Size by Country

6.4.1 North America Blood Cancer Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Blood Cancer Therapeutics Market Size by Country (2019-2024)

6.4.3 North America Blood Cancer Therapeutics Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Blood Cancer Therapeutics Market Size (2019-2030)

7.2 Europe Blood Cancer Therapeutics Market Size by Type

7.2.1 Europe Blood Cancer Therapeutics Market Size by Type (2019-2024)

7.2.2 Europe Blood Cancer Therapeutics Market Size by Type (2025-2030)

7.2.3 Europe Blood Cancer Therapeutics Market Share by Type (2019-2030)

7.3 Europe Blood Cancer Therapeutics Market Size by Application

7.3.1 Europe Blood Cancer Therapeutics Market Size by Application (2019-2024)

7.3.2 Europe Blood Cancer Therapeutics Market Size by Application (2025-2030)

7.3.3 Europe Blood Cancer Therapeutics Market Share by Application (2019-2030)

7.4 Europe Blood Cancer Therapeutics Market Size by Country

7.4.1 Europe Blood Cancer Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Blood Cancer Therapeutics Market Size by Country (2019-2024)

7.4.3 Europe Blood Cancer Therapeutics Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Blood Cancer Therapeutics Market Size (2019-2030)

8.2 China Blood Cancer Therapeutics Market Size by Type

8.2.1 China Blood Cancer Therapeutics Market Size by Type (2019-2024)

8.2.2 China Blood Cancer Therapeutics Market Size by Type (2025-2030)

8.2.3 China Blood Cancer Therapeutics Market Share by Type (2019-2030)

8.3 China Blood Cancer Therapeutics Market Size by Application

8.3.1 China Blood Cancer Therapeutics Market Size by Application (2019-2024)

8.3.2 China Blood Cancer Therapeutics Market Size by Application (2025-2030)

8.3.3 China Blood Cancer Therapeutics Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Blood Cancer Therapeutics Market Size (2019-2030)

9.2 Asia Blood Cancer Therapeutics Market Size by Type

9.2.1 Asia Blood Cancer Therapeutics Market Size by Type (2019-2024)

9.2.2 Asia Blood Cancer Therapeutics Market Size by Type (2025-2030)

9.2.3 Asia Blood Cancer Therapeutics Market Share by Type (2019-2030)

9.3 Asia Blood Cancer Therapeutics Market Size by Application

9.3.1 Asia Blood Cancer Therapeutics Market Size by Application (2019-2024)

9.3.2 Asia Blood Cancer Therapeutics Market Size by Application (2025-2030)

9.3.3 Asia Blood Cancer Therapeutics Market Share by Application (2019-2030)

9.4 Asia Blood Cancer Therapeutics Market Size by Region

9.4.1 Asia Blood Cancer Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Blood Cancer Therapeutics Market Size by Region (2019-2024)

9.4.3 Asia Blood Cancer Therapeutics Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Size by Type

10.2.1 Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Size by Application

10.3.1 Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Size by Country

10.4.1 Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 AbbVie

11.1.1 AbbVie Company Details

11.1.2 AbbVie Business Overview

11.1.3 AbbVie Blood Cancer Therapeutics Introduction

11.1.4 AbbVie Revenue in Blood Cancer Therapeutics Business (2019-2024)

11.1.5 AbbVie Recent Developments

11.2 AstraZeneca

11.2.1 AstraZeneca Company Details

11.2.2 AstraZeneca Business Overview

11.2.3 AstraZeneca Blood Cancer Therapeutics Introduction

11.2.4 AstraZeneca Revenue in Blood Cancer Therapeutics Business (2019-2024)

11.2.5 AstraZeneca Recent Developments

11.3 Bristol-Myers Squibb

11.3.1 Bristol-Myers Squibb Company Details

11.3.2 Bristol-Myers Squibb Business Overview

11.3.3 Bristol-Myers Squibb Blood Cancer Therapeutics Introduction

11.3.4 Bristol-Myers Squibb Revenue in Blood Cancer Therapeutics Business (2019-2024)

11.3.5 Bristol-Myers Squibb Recent Developments

11.4 GlaxoSmithKline

11.4.1 GlaxoSmithKline Company Details

11.4.2 GlaxoSmithKline Business Overview

11.4.3 GlaxoSmithKline Blood Cancer Therapeutics Introduction

11.4.4 GlaxoSmithKline Revenue in Blood Cancer Therapeutics Business (2019-2024)

11.4.5 GlaxoSmithKline Recent Developments

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Blood Cancer Therapeutics Introduction

11.5.4 Roche Revenue in Blood Cancer Therapeutics Business (2019-2024)

11.5.5 Roche Recent Developments

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Blood Cancer Therapeutics Introduction

11.6.4 Novartis Revenue in Blood Cancer Therapeutics Business (2019-2024)

11.6.5 Novartis Recent Developments

11.7 Boehringer Ingelheim

11.7.1 Boehringer Ingelheim Company Details

11.7.2 Boehringer Ingelheim Business Overview

11.7.3 Boehringer Ingelheim Blood Cancer Therapeutics Introduction

11.7.4 Boehringer Ingelheim Revenue in Blood Cancer Therapeutics Business (2019-2024)

11.7.5 Boehringer Ingelheim Recent Developments

11.8 Pfizer

11.8.1 Pfizer Company Details

11.8.2 Pfizer Business Overview

11.8.3 Pfizer Blood Cancer Therapeutics Introduction

11.8.4 Pfizer Revenue in Blood Cancer Therapeutics Business (2019-2024)

11.8.5 Pfizer Recent Developments

11.9 Sanofi

11.9.1 Sanofi Company Details

11.9.2 Sanofi Business Overview

11.9.3 Sanofi Blood Cancer Therapeutics Introduction

11.9.4 Sanofi Revenue in Blood Cancer Therapeutics Business (2019-2024)

11.9.5 Sanofi Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global Blood Cancer Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Chronic Myeloid Leukemia (CML)

Table 3. Key Players of Acute Lymphocytic Leukemia (ALL)

Table 4. Key Players of Chronic Lymphocytic Leukemia (CLL)

Table 5. Key Players of Acute Myeloid Leukemia (AML)

Table 6. Global Blood Cancer Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global Blood Cancer Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Blood Cancer Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Blood Cancer Therapeutics Market Share by Region (2019-2024)

Table 10. Global Blood Cancer Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Blood Cancer Therapeutics Market Share by Region (2025-2030)

Table 12. Blood Cancer Therapeutics Market Trends

Table 13. Blood Cancer Therapeutics Market Drivers

Table 14. Blood Cancer Therapeutics Market Challenges

Table 15. Blood Cancer Therapeutics Market Restraints

Table 16. Global Blood Cancer Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Blood Cancer Therapeutics Revenue Share by Players (2019-2024)

Table 18. Global Top Blood Cancer Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Cancer Therapeutics as of 2023)

Table 19. Global Blood Cancer Therapeutics Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by Blood Cancer Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of Blood Cancer Therapeutics, Headquarters and Area Served

Table 22. Global Key Players of Blood Cancer Therapeutics, Product and Application

Table 23. Global Key Players of Blood Cancer Therapeutics, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Blood Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Blood Cancer Therapeutics Revenue Market Share by Type (2019-2024)

Table 27. Global Blood Cancer Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Blood Cancer Therapeutics Revenue Market Share by Type (2025-2030)

Table 29. Global Blood Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Blood Cancer Therapeutics Revenue Share by Application (2019-2024)

Table 31. Global Blood Cancer Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Blood Cancer Therapeutics Revenue Share by Application (2025-2030)

Table 33. North America Blood Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America Blood Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America Blood Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America Blood Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America Blood Cancer Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America Blood Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America Blood Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe Blood Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe Blood Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe Blood Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe Blood Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe Blood Cancer Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe Blood Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe Blood Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 47. China Blood Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 48. China Blood Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 49. China Blood Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 50. China Blood Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia Blood Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia Blood Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia Blood Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia Blood Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia Blood Cancer Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia Blood Cancer Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia Blood Cancer Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Blood Cancer Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 65. AbbVie Company Details

Table 66. AbbVie Business Overview

Table 67. AbbVie Blood Cancer Therapeutics Product

Table 68. AbbVie Revenue in Blood Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 69. AbbVie Recent Developments

Table 70. AstraZeneca Company Details

Table 71. AstraZeneca Business Overview

Table 72. AstraZeneca Blood Cancer Therapeutics Product

Table 73. AstraZeneca Revenue in Blood Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 74. AstraZeneca Recent Developments

Table 75. Bristol-Myers Squibb Company Details

Table 76. Bristol-Myers Squibb Business Overview

Table 77. Bristol-Myers Squibb Blood Cancer Therapeutics Product

Table 78. Bristol-Myers Squibb Revenue in Blood Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 79. Bristol-Myers Squibb Recent Developments

Table 80. GlaxoSmithKline Company Details

Table 81. GlaxoSmithKline Business Overview

Table 82. GlaxoSmithKline Blood Cancer Therapeutics Product

Table 83. GlaxoSmithKline Revenue in Blood Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 84. GlaxoSmithKline Recent Developments

Table 85. Roche Company Details

Table 86. Roche Business Overview

Table 87. Roche Blood Cancer Therapeutics Product

Table 88. Roche Revenue in Blood Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 89. Roche Recent Developments

Table 90. Novartis Company Details

Table 91. Novartis Business Overview

Table 92. Novartis Blood Cancer Therapeutics Product

Table 93. Novartis Revenue in Blood Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 94. Novartis Recent Developments

Table 95. Boehringer Ingelheim Company Details

Table 96. Boehringer Ingelheim Business Overview

Table 97. Boehringer Ingelheim Blood Cancer Therapeutics Product

Table 98. Boehringer Ingelheim Revenue in Blood Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 99. Boehringer Ingelheim Recent Developments

Table 100. Pfizer Company Details

Table 101. Pfizer Business Overview

Table 102. Pfizer Blood Cancer Therapeutics Product

Table 103. Pfizer Revenue in Blood Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 104. Pfizer Recent Developments

Table 105. Sanofi Company Details

Table 106. Sanofi Business Overview

Table 107. Sanofi Blood Cancer Therapeutics Product

Table 108. Sanofi Revenue in Blood Cancer Therapeutics Business (2019-2024) & (US$ Million)

Table 109. Sanofi Recent Developments

Table 110. Research Programs/Design for This Report

Table 111. Key Data Information from Secondary Sources

Table 112. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Blood Cancer Therapeutics Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Blood Cancer Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Chronic Myeloid Leukemia (CML) Features

Figure 4. Acute Lymphocytic Leukemia (ALL) Features

Figure 5. Chronic Lymphocytic Leukemia (CLL) Features

Figure 6. Acute Myeloid Leukemia (AML) Features

Figure 7. Global Blood Cancer Therapeutics Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Blood Cancer Therapeutics Market Share by Application: 2023 VS 2030

Figure 9. Cancer Research Centers Case Studies

Figure 10. Cancer Hospital Case Studies

Figure 11. Surgical Centers Case Studies

Figure 12. Clinics Case Studies

Figure 13. Blood Cancer Therapeutics Report Years Considered

Figure 14. Global Blood Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Blood Cancer Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Blood Cancer Therapeutics Market Share by Region: 2023 VS 2030

Figure 17. Global Blood Cancer Therapeutics Market Share by Players in 2023

Figure 18. Global Top Blood Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Cancer Therapeutics as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Blood Cancer Therapeutics Revenue in 2023

Figure 20. North America Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Blood Cancer Therapeutics Market Share by Type (2019-2030)

Figure 22. North America Blood Cancer Therapeutics Market Share by Application (2019-2030)

Figure 23. North America Blood Cancer Therapeutics Market Share by Country (2019-2030)

Figure 24. United States Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Blood Cancer Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 27. Europe Blood Cancer Therapeutics Market Share by Type (2019-2030)

Figure 28. Europe Blood Cancer Therapeutics Market Share by Application (2019-2030)

Figure 29. Europe Blood Cancer Therapeutics Market Share by Country (2019-2030)

Figure 30. Germany Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China Blood Cancer Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 37. China Blood Cancer Therapeutics Market Share by Type (2019-2030)

Figure 38. China Blood Cancer Therapeutics Market Share by Application (2019-2030)

Figure 39. Asia Blood Cancer Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 40. Asia Blood Cancer Therapeutics Market Share by Type (2019-2030)

Figure 41. Asia Blood Cancer Therapeutics Market Share by Application (2019-2030)

Figure 42. Asia Blood Cancer Therapeutics Market Share by Region (2019-2030)

Figure 43. Japan Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. South Korea Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. China Taiwan Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. India Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Australia Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Size YoY (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Share by Type (2019-2030)

Figure 51. Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Share by Application (2019-2030)

Figure 52. Middle East, Africa, and Latin America Blood Cancer Therapeutics Market Share by Country (2019-2030)

Figure 53. Brazil Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Mexico Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Turkey Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Israel Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GCC Countries Blood Cancer Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. AbbVie Revenue Growth Rate in Blood Cancer Therapeutics Business (2019-2024)

Figure 60. AstraZeneca Revenue Growth Rate in Blood Cancer Therapeutics Business (2019-2024)

Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Blood Cancer Therapeutics Business (2019-2024)

Figure 62. GlaxoSmithKline Revenue Growth Rate in Blood Cancer Therapeutics Business (2019-2024)

Figure 63. Roche Revenue Growth Rate in Blood Cancer Therapeutics Business (2019-2024)

Figure 64. Novartis Revenue Growth Rate in Blood Cancer Therapeutics Business (2019-2024)

Figure 65. Boehringer Ingelheim Revenue Growth Rate in Blood Cancer Therapeutics Business (2019-2024)

Figure 66. Pfizer Revenue Growth Rate in Blood Cancer Therapeutics Business (2019-2024)

Figure 67. Sanofi Revenue Growth Rate in Blood Cancer Therapeutics Business (2019-2024)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-11W14373

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Hurthle Cell Carcinoma Treatment Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-35B1140

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Anaplastic Large Cell Lymphoma Drugs Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-27H888

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

Global Anaplastic Large Cell Lymphoma Market Insights, Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-16R5994

Fri Dec 27 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Blood Cancer Therapeutics Market Insights, Forecast to 2030

Published Date: December 2024

Report Code: QYRE-Auto-16L13306

Global Blood Cancer Therapeutics Market Insights, Forecast to 2030

FEATURED COMPANIES

Blood Cancer Therapeutics Market Size

Blood Cancer Therapeutics Market

Scope of Blood Cancer Therapeutics Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Blood Cancer Therapeutics Market report?

What are the Application segmentation covered in the Blood Cancer Therapeutics Market report?

What are the Type segmentation covered in the Blood Cancer Therapeutics Market report?

FEATURED COMPANIES

RELATED REPORTS